Hypofractionated Radiation Therapy Versus Conventional Radiation Therapy in Patients With Intermediate- to High-Risk Localized Prostate Cancer

被引：0

作者：

Guo, W. ^{[1
]}

Gao, X. S. ^{[1
]}

Gu, X. ^{[1
]}

Ma, M. ^{[1
]}

机构：

[1] Peking Univ, Hosp 1, Dept Radiat Oncol, Beijing, Peoples R China

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期

关键词：

D O I：

10.1016/j.ijrobp.2017.06.1169

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2567

引用

页码：E236 / E237

页数：2

共 50 条

[21] Trends in Androgen Deprivation Therapy Use With Radiation for Intermediate- and High-Risk Prostate Cancer Across the United States [J].

Falchook, A. ;

Mohiuddin, J. J. ;

Chen, R. C. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03) :S45-S45

[22] Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer [J].

Yang, Jing ;

Qi, Shu-Nan ;

Fang, Hui ;

Song, Yong-Wen ;

Jin, Jing ;

Liu, Yue-Ping ;

Wang, Wei-Hu ;

Yang, Yong ;

Tang, Yu ;

Ren, Hua ;

Chen, Bo ;

Lu, Ning-Ning ;

Tang, Yuan ;

Li, Ning ;

Jing, Hao ;

Wang, Shu-Lian ;

Li, Ye-Xiong .

BREAST, 2021, 58 :72-79

[23] Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer: A Meta-analysis of Randomized Noninferiority Trials [J].

Royce, Trevor Joseph ;

Lee, Dong Hoon ;

Keum, NaNa ;

Permpalung, Nitipong ;

Chiew, Calvin J. ;

Epstein, Sherise ;

Pluchino, Kristen M. ;

D'Amico, Anthony V. .

EUROPEAN UROLOGY FOCUS, 2019, 5 (04) :577-584

[24] APPLICABILITY ANALYSIS OF FOCAL THERAPY TO INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER [J].

Matsuoka, Yoh ;

Numao, Noboru ;

Saito, Kazutaka ;

Tanaka, Hiroshi ;

Inoue, Masaharu ;

Ito, Masaya ;

Yoshida, Soichiro ;

Yokoyama, Minato ;

Ishioka, Junichiro ;

Fujii, Yasuhisa ;

Kihara, Kazunori .

JOURNAL OF UROLOGY, 2016, 195 (04) :E195-E195

[25] Accelerated hypofractionated radiation therapy with neoadjuvant and concomitant hormone therapy for intermediate risk prostate cancer [J].

Yassa, M. ;

Fortin, B. ;

Fortin, M-A. ;

Lambert, C. ;

Nguyen, T. V. ;

Bahary, J-P. .

RADIOTHERAPY AND ONCOLOGY, 2006, 81 :S439-S439

[26] Accelerated hypofractionated radiation therapy with neoadjuvant and concomitant hormone therapy for intermediate risk prostate cancer [J].

Yassa, M. ;

Fortin, B. ;

Lambert, C. ;

Nguyen, T. ;

Fortin, M. ;

Bahary, J. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03) :S347-S348

[27] Effects of hypofractionated radiation therapy for men with localized prostate cancer [J].

Mattigk, A. ;

Zengerling, F. .

UROLOGE, 2020, 59 (08) :953-956

[28] Good tolerability of hypofractionated radiation therapy for localized prostate cancer [J].

Navarro, I. ;

Correa, R. ;

Otero, A. ;

Roman, A. ;

Zapata, I. ;

Fernandez, A. ;

Prieto, P. ;

Segado, S. ;

Jodar, C. ;

Garrido, C. ;

Medina, J. A. ;

Gomez, J. .

RADIOTHERAPY AND ONCOLOGY, 2019, 133 :S853-S854

[29] HYPOFRACTIONATED RADIATION THERAPY (RT) FOR LOCALIZED PROSTATE CANCER (PC) [J].

Rene, N. ;

Faria, S. ;

Souhami, L. ;

Cury, F. ;

David, M. ;

Shenouda, G. ;

Duclos, M. .

RADIOTHERAPY AND ONCOLOGY, 2009, 92 :S10-S11

[30] Molecular correlates of intermediate- and high-risk localized prostate cancer [J].

Ye, Huihui ;

Sowalsky, Adam G. .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) :368-374

← 1 2 3 4 5 →